The Evolution Of Flu, Common Cold And The OTC Cough & Cold Market
The evolution of flu and common cold: health impact and growth of the OTC Cough & Cold market Every winter, influenza and the common cold once again rank among the leading global public health challenges. It is estimated that nearly 1 billion people worldwide are affected each year by seasonal respiratory infections, generating a significant […]
Farmalider Receives the 2025 CIEGE Certificate of Excellence in Business Management and Ranks Above the Average of Certified Companies
The CIEGE Certificate, promoted by elEconomista.es and Informa D&B, is based on one of the most rigorous evaluations on the market, with more than 50 indicators grouped into 10 key areas. Farmalider achieved a score of 76%, exceeding the required criteria and ranking more than ten points above the historical average of certified companies, reinforcing […]
International Collaboration in Biotechnology and Pharmaceutical Innovation: Farmalider Welcomes the Shanghai Delegation
Pharmaceutical innovation is global. Yesterday, we had the honor of welcoming the Shanghai Municipal Government Delegation to our Madrid offices, where they visited FARMALIDER to explore opportunities for collaboration in biopharmaceutical and innovation-driven projects. The delegation was led by: During the visit, we shared our experience as a pharmaceutical group in development, manufacturing, and innovation, […]
López Bran, the Spanish doctor who could put an end to baldness with stem cells: “In 4 years we could have the therapy.”
A stem cell–based therapy has succeeded in regenerating hair in mice with induced androgenetic alopecia. This has been achieved by a team of Spanish researchers led by Eduardo López Bran, Head of Dermatology at Hospital Clínico San Carlos in Madrid. López Bran and his team extracted stem cells from adipose tissue (body fat), cultured them, […]
Is the End of Baldness Near? This Is the Spanish Stem Cell–Based Solution That Has Worked in Mice
A ray of hope for people seeking to put an end to alopecia. A study conducted by the Department of Dermatology at Hospital Clínico San Carlos in Madrid promises to offer a solution for those who want to reverse baldness or prevent it, according to an article published in the journal Stem Cell Research & […]
Ideeea Tx announces AGAcell, a cell therapy program for alopecia
Ideeea Therapeutics has closed a €2.3 million seed funding round to drive the development of advanced therapy medicinal products, following an open science approach and aiming for high clinical impact. This financing round will make it possible to accelerate AGAcell, a product developed by Ideeea. AGAcell is a preclinical research program that explores the intradermal […]
Farmalider Group and MASPV collaborate to drive green energy forward
The strategic alliance between Farmalider Group and MASPV will reduce their carbon footprint by 70 tonnes of CO₂ per year, equivalent to saving 63 tonnes of coal and preserving 777 trees annually. In this way, Farmalider Group demonstrates its commitment to the health of both patients and the planet. Farmalider Group, a benchmark in pharmaceutical […]